• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌R0切除术后的疾病复发模式。

Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma.

作者信息

Kobayashi A, Miwa S, Nakata T, Miyagawa S

机构信息

First Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Japan.

出版信息

Br J Surg. 2010 Jan;97(1):56-64. doi: 10.1002/bjs.6788.

DOI:10.1002/bjs.6788
PMID:19937985
Abstract

BACKGROUND

There is little information regarding the clinical behaviour of hilar cholangiocarcinoma after curative resection.

METHODS

A retrospective study was undertaken of 79 consecutive patients with hilar cholangiocarcinoma who had undergone major hepatectomy (three or more Couinaud segments) concomitant with caudate lobectomy, and had negative resection margins. Sites of initial disease recurrence were classified as locoregional (porta hepatis) or distant (intrahepatic, peritoneal, para-aortic lymph nodal or extra-abdominal). Univariable and multivariable analyses were performed to determine the factors potentially related to recurrence.

RESULTS

Disease recurrence was observed in 42 (53 per cent) of the 79 patients. Cumulative recurrence rates at 3 and 4 years after surgery were 52 and 56 per cent respectively. Locoregional recurrence alone was observed in eight (10 per cent) and distant metastasis in 34 (43 per cent) of the 79 patients after R0 resection. Positive nodal involvement and high International Union Against Cancer tumour (T) stage were independent prognostic factors associated with distant metastasis.

CONCLUSION

Distant metastases are more common than locoregional recurrence after R0 resection for hilar cholangiocarcinoma, and associated with nodal involvement and high T stage.

摘要

背景

关于肝门部胆管癌根治性切除术后的临床行为,相关信息较少。

方法

对79例连续的肝门部胆管癌患者进行回顾性研究,这些患者均接受了扩大肝切除术(三个或更多Couinaud肝段)并同时行尾状叶切除术,且手术切缘阴性。初始疾病复发部位分为局部区域(肝门部)或远处(肝内、腹膜、腹主动脉旁淋巴结或腹外)。进行单因素和多因素分析以确定可能与复发相关的因素。

结果

79例患者中有42例(53%)出现疾病复发。术后3年和4年的累积复发率分别为52%和56%。在79例患者中,R0切除术后仅观察到8例(10%)局部区域复发和34例(43%)远处转移。阳性淋巴结受累和国际抗癌联盟高肿瘤(T)分期是与远处转移相关的独立预后因素。

结论

对于肝门部胆管癌,R0切除术后远处转移比局部区域复发更常见,且与淋巴结受累和高T分期相关。

相似文献

1
Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma.肝门部胆管癌R0切除术后的疾病复发模式。
Br J Surg. 2010 Jan;97(1):56-64. doi: 10.1002/bjs.6788.
2
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.肝门部胆管癌切除术:同期肝切除可降低肝内复发率。
Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.
3
Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.肝门部胆管癌的扩大肝切除术:46例患者分析
Arch Surg. 2004 May;139(5):514-23; discussion 523-5. doi: 10.1001/archsurg.139.5.514.
4
[Partial hepatectomy with skeletonization of the hepatoduodenal ligament for hilar cholangiocarcinoma].[肝十二指肠韧带骨骼化的肝门胆管癌根治性肝切除术]
Zhonghua Wai Ke Za Zhi. 2004 Feb 22;42(4):210-2.
5
Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.肝内胆管癌根治性切除术后的淋巴结比率
Br J Surg. 2009 Aug;96(8):919-25. doi: 10.1002/bjs.6654.
6
Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.肝门部胆管癌的切除与引流:中国大陆单中心11年经验
Am Surg. 2011 May;77(5):627-33.
7
Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.肝门部胆管癌行扩大胆管切除和[校正]肝移植:长期结果。
Liver Transpl. 2009 Nov;15(11):1499-507. doi: 10.1002/lt.21887.
8
Aggressive surgical resection for hilar cholangiocarcinoma.肝门部胆管癌的积极手术切除
ANZ J Surg. 2005 Nov;75(11):981-5. doi: 10.1111/j.1445-2197.2005.03595.x.
9
Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.3型和4型肝门部胆管癌的扩大肝切除术:预后因素及长期疗效
J Am Coll Surg. 2007 Feb;204(2):250-60. doi: 10.1016/j.jamcollsurg.2006.10.028. Epub 2006 Dec 27.
10
Treatment strategy for patients with middle and lower third bile duct cancer.中下段胆管癌患者的治疗策略
Br J Surg. 2001 Mar;88(3):364-70. doi: 10.1046/j.1365-2168.2001.01685.x.

引用本文的文献

1
Recommendations for the Clinical Practice concerning the Use of Cholangiopancreatoscopy: Proceedings from a Consensus Meeting.关于胆管胰管镜检查临床应用的临床实践建议:共识会议纪要
GE Port J Gastroenterol. 2025 Apr 8:1-21. doi: 10.1159/000545718.
2
Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.肝门部胆管癌手术治疗的临床特征及长期生存预测。
PLoS One. 2024 Jul 1;19(7):e0304838. doi: 10.1371/journal.pone.0304838. eCollection 2024.
3
Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma.
肝门周围胆管癌手术切除后预测复发和生存的影像学特征。
Heliyon. 2024 Mar 29;10(7):e28805. doi: 10.1016/j.heliyon.2024.e28805. eCollection 2024 Apr 15.
4
Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma.开发和验证一种新的术前临床模型,用于预测肝门周围胆管癌的淋巴结转移。
BMC Cancer. 2024 Mar 4;24(1):297. doi: 10.1186/s12885-024-12068-1.
5
Transplant Oncology: An Emerging Discipline of Cancer Treatment.移植肿瘤学:癌症治疗的一门新兴学科。
Cancers (Basel). 2023 Nov 9;15(22):5337. doi: 10.3390/cancers15225337.
6
Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer.辅助化疗在胆道癌患者中的实施难度。
Langenbecks Arch Surg. 2023 Nov 24;408(1):445. doi: 10.1007/s00423-023-03169-9.
7
Precise mapping of hilar cholangiocarcinoma with a skip lesion by SpyGlass cholangioscopy: A case report.使用SpyGlass胆道镜对伴有跳跃性病变的肝门部胆管癌进行精确 mapping:病例报告。 (注:这里“mapping”结合语境可能不太好直接准确翻译,可根据实际情况进一步优化表述,比如“定位”等,但按要求需保留原文)
World J Gastrointest Surg. 2023 May 27;15(5):965-971. doi: 10.4240/wjgs.v15.i5.965.
8
Surgical treatment for recurrent cholangiocarcinoma: a single-center series.复发性胆管癌的外科治疗:单中心病例系列研究
Front Oncol. 2023 Apr 18;13:1169133. doi: 10.3389/fonc.2023.1169133. eCollection 2023.
9
Locoregional Approaches in Cholangiocarcinoma Treatment.胆管癌治疗中的局部区域治疗方法。
Cancers (Basel). 2022 Nov 28;14(23):5853. doi: 10.3390/cancers14235853.
10
Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?胆管癌复发的解剖学模式:原发肿瘤部位重要吗?
J Gastrointest Oncol. 2022 Jun;13(3):1413-1422. doi: 10.21037/jgo-21-868.